Disuse‐induced muscle fibrosis, cellular senescence, and senescence‐associated secretory phenotype in older adults are alleviated during re‐ambulation with metformin pre‐treatment
Aging Cell · 2023-11 · 22 (11)
DOI: 10.1111/acel.13936 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Aging Cell, online erschienen am 24.07.2023. Verfasst von Jonathan J Petrocelli und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Metformin. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIDDK NIH HHS, NIA NIH HHS.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Muscle inflammation and fibrosis underlie disuse‐related complications and may contribute to impaired muscle recovery in aging. Cellular senescence is an emerging link between inflammation, extracellular matrix (ECM) remodeling and poor muscle recovery after disuse. In rodents, metformin has been shown to prevent cellular senescence/senescent associated secretory phenotype (SASP), inflammation, and fibrosis making it a potentially practical therapeutic solution. Thus, the purpose of this study was to determine in older adults if metformin monotherapy during bed rest could reduce muscle fibrosis and cellular senescence/SASP during the re‐ambulation period. A two‐arm controlled trial was utilized in healthy male and female older adults ( n = 20; BMI:
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA.
- Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.
- Department of Kinesiology, Nutrition, and Health, Miami University, Oxford, Ohio, USA.
- Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.
- Center for Muscle Biology, University of Kentucky, Lexington, Kentucky, USA.
- Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
ORCID-Profile: Micah J Drummond
Förderung
- NCATS NIH HHS
- NIDDK NIH HHS
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Petrocelli, J. J., McKenzie, A. I., de Hart, N. M. M. P., Reidy, P. T., Mahmassani, Z. S., Keeble, A. R., Kaput, K. L., Wahl, M. P., Rondina, M. T., Marcus, R. L., Welt, C. K., Holland, W. L., Funai, K., Fry, C. S., & Drummond, M. J. (2023). Disuse‐induced muscle fibrosis, cellular senescence, and senescence‐associated secretory phenotype in older adults are alleviated during re‐ambulation with metformin pre‐treatment. Aging Cell, 22(11). https://doi.org/10.1111/acel.13936
Vancouver
Petrocelli JJ, McKenzie AI, de Hart NMMP, Reidy PT, Mahmassani ZS, Keeble AR, et al. Disuse‐induced muscle fibrosis, cellular senescence, and senescence‐associated secretory phenotype in older adults are alleviated during re‐ambulation with metformin pre‐treatment. Aging Cell. 2023;22(11). doi:10.1111/acel.13936
BibTeX
@article{Petrocelli2023,
author = {Petrocelli, Jonathan J and McKenzie, Alec I and de Hart, Naomi M M P and Reidy, Paul T and Mahmassani, Ziad S and Keeble, Alexander R and Kaput, Katie L and Wahl, Matthew P and Rondina, Matthew T and Marcus, Robin L and Welt, Corrine K and Holland, William L and Funai, Katsuhiko and Fry, Christopher S and Drummond, Micah J},
title = {Disuse‐induced muscle fibrosis, cellular senescence, and senescence‐associated secretory phenotype in older adults are alleviated during re‐ambulation with metformin pre‐treatment},
journal = {Aging Cell},
year = {2023},
volume = {22},
number = {11},
doi = {10.1111/acel.13936}
}
EUVIMED